|
Robert A. Hamm is our Executive Vice President, Pharmaceutical Operations & Technology and has served in that position since October 2007. Prior to that, Mr. Hamm had served as our Senior Vice President, Neurology Strategic Business Unit since January 2006. He became Senior Vice President, Immunology Business Unit after the merger in November 2003 and served in the same capacity with Biogen Inc. from November 2002 until the merger. Since joining Biogen in 1994, Mr. Hamm has served in a variety of positions of increasing responsibility, including Senior Vice President, Europe, Africa, Canada and Middle East from October 2001 to November 2002; Vice President, Sales and Marketing of Biogen from October 2000 to October 2001; Vice President, Manufacturing from June 1999 to October 2000; and Director, Northern Europe and Distributors from November 1996 until June 1999. From 1987 to 1994, Mr. Hamm held a variety of management positions at Syntex Laboratories Corp., including Director of Operations and New Product Planning, and Manager of Materials, Logistics and Contract Manufacturing.
| 